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Abstract 
Purpose: To investigate the anti-oxidant and anti-neuroinflammatory effects of Salicornia bigelovii 
extract (SBE) in lipopolysaccharide (LPS)-stimulated BV-2 microglial cells. 
Methods:  Anti-oxidant activity was measured using 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical 
scavenging assay. Cell viability was evaluated using 3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyl-
tetrazolium bromide (MTT) assay. BV- microglial cells were stimulated with LPS to study the protein 
expression and production of inflammatory mediators, determined by Western blot analysis.  
Results: SBE significantly inhibited the DPPH-generated free radicals showing maximum inhibition at 
40 µg/mL (p < 0.001). SBE alone did not exhibit any signs of cytotoxicity to BV-2 cells up to 200 µg/mL 
concentration. The LPS-induced increase in the production of nitric oxide was concentration-
dependently suppressed by SBE (p < 0.05 for 10 µg/mL, p < 0.01 at 20 µg/mL and p < 0.001 at 40 
µg/mL, respectively). SBE also inhibited the LPS-induced increase in inducible nitric oxide synthase 
(iNOS) and cyclooxygenase-2 (COX-2) expressions. Further, the production of proinflammatory 
cytokines such as tumor necrosis factor-α and interleukin-6 by LPS-stimulation in BV-2 cells was 
inhibited by SBE pretreatment. Mechanistic study revealed that SBE acts by regulation of nuclear factor 
kappa-B signaling pathway in LPS-stimulated BV-2 microglial cells.  
Conclusion: This study revealed for the first time that SBE possesses anti-oxidant and anti-
neuroinflammatory effects and can be developed as a potential therapeutic target in ameliorating 
microglia-mediated neuroinflammation. 
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Salicornia bigelovii Torr. (S. bigelovii) commonly 
known as “Dwarf saltwort” from the family 
Amaranthaceae, is a leafless annual salt-marsh 
herb with green jointed and succulent stems [1]. 
S. bigelovii has an exceptional salt tolerance, 
adaptation to marginal lands and hot climates, 
therefore has great potential as a domesticated 
biomass, oilseed, and forage crop plant [2]. S. 
bigelovii has been successfully cultivated as an 
oilseed and vegetable crop in the desert 
coastlines of Mexico, India, the Middle East, 
Africa and in Southeast China [3]. The seed is 
rich in oil (30%) and protein (35%) with a high 
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content of polyunsaturated linoleic (75%) and 
linolenic (omega-3) fatty acids. In addition to its 
value in human diet, the oil can be used for the 
production of biodiesel [4]. Earlier studies 
suggested that Salicornia species has been used 
as a folk medicine to treat a variety of diseases 
such as atherosclerosis, hypertension, tumors 
and claimed as one of the most promising 
halophytes as immunomodulators [3,5]. 
However, till date there have been no reports on 
the antioxidant and anti-neuroinflammatory 
properties of S. bigelovii.  
 
Microglia, the resident immune cells of the 
central nervous system, become activated 
thereby inducing significant and highly 
detrimental neurotoxic effects by excessively 
producing a large array of cytotoxic and 
proinflammatory factors [6]. Microglia-mediated 
neuroinflammation appears to play an essential 
role in the pathogenesis of various 
neurodegenerative diseases such as Alzheimer’s 
disease, Parkinson’s disease and multiple 
sclerosis [7]. Previous reports strongly 
demonstrated that regulation of microglial 
activation could reduce neuroinflammation and 
further neuronal cell damage [8].  
 
Lipopolysaccharide (LPS) is a common toxin 
used to investigate the impact of inflammation on 
neuronal death. LPS can directly activate 
microglia triggering the production of 
inflammatory mediators, such as nitric oxide 
(NO), cyclooxygenase (COX)-2, pro-
inflammatory cytokines and leukotrienes [9]. 
Therefore, LPS-induced inflammatory mediators 
in vitro can be considered as one of the 
important tools to evaluate new and existing 
agents for their anti-neuroinflammatory actions. 
Recent studies have shown a convincing link 
between reactive oxygen species (ROS) and 
neuroinflammation. Inhibition of ROS by several 
anti-oxidants may suppress microglial activation 
and thus protect neuronal cell death [10,11]. In 
this study we evaluated the antioxidant potential 
and anti-neuroinflammatory properties of S. 
bigelovii extract in LPS-stimulated BV-2 




Preparation of S. bigelovii extract 
 
The dried whole plant of S. bigelovii (5 kg) 
collected during May 2012, were purchased from 
a local market in South Korea and authenticated 
by Prof Jong-Bo Kim, a taxonomist at Konkuk 
University, South Korea. A voucher specimen 
(SB-KU2012) has been kept in our laboratory 
herbarium, Konkuk University, South Korea, for 
future reference. To obtain the S. bigelovii 
extract, the dried plant material was ground in a 
blender and defatted three times with three 
volumes of ethanol. The residue was extracted 
with absolute ethanol at 1:10 ratio (w/v) for 2 h in 
a heating mantle at 70 - 80 °C, and the 
supernatant was filtered and concentrated in a 
vacuum evaporator system at 50°C. For further 
fractionation, the extract (1 kg) was partitioned 
into hexane, chloroform and ethyl acetate 
fractions to yield 220 mg, 50 mg and 456 mg, 
respectively. The active ethyl acetate fraction of 
S. bigelovii extract (SBE, 45.6%) was lyophilized 
and stored in a refrigerator (-20 °C) until use. 
SBE extract was re-dissolved in distilled water 
and filtered on 0.22 μm filters to evaluate its anti-
oxidant and anti-neuroinflammatory activities.  
 
DPPH radical scavenging activity  
 
The anti-oxidant activity of the SBE was 
determined using the stable radical 2, 2-
diphenyl-1-picrylhydrazyl (DPPH, Sigma-Aldrich, 
St. Louis, MO, USA). The radical scavenging 
capacity was evaluated by employing a reaction 
mixture constituted by aliquots of the SBE 
extract and a DPPH methanolic solution as 
described previously [12]. Briefly, a sample 
solution of 60 µl of each OFP-EA extract, was 
added to 60 µl of DPPH (60 µM) in methanol. 
After mixing vigorously for 10 s, the mixture was 
then transferred into a 100 µl Teflon capillary 
tube and the scavenging activity of each sample 
on DPPH radical was measured using a JES-FA 
ESR spectrometer (Jeol Ltd., Tokyo, Japan). A 
spin adduct was measured on an ESR 
spectrometer exactly after 2 min. Experimental 
conditions were as follows: central field, 3,475 G; 
modulation frequency, 100 kHz; modulation 
amplitude, 2 G; microwave power, 5 mW; gain, 
6.3 x 105, and temperature, 298°K. 
 
Cell cultures and viability 
 
BV-2 microglia cells were cultured at 37 °C in 5 
% CO2 in DMEM (Invitrogen, Carlsbad, CA, 
USA) supplemented with 5 % foetal bovine 
serum (FBS, Hyclone, Logan, UT, USA) and 50 
μg/ml penicillin-streptomycin (Invitrogen). In all 
experiments, cells were pre-treated with the 
indicated concentrations of SBE for 1 h before 
the addition of LPS (1 μg/ml, Sigma-Aldrich, St 
Louis, MO, USA) in serum free DMEM. An equal 
volume of sterile water was added to all control 
treatments. Cell viability was determined by 3-(4, 
5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay as described previously 
[13]. Cells were incubated with various 
concentrations (0.1, 1.0, 10, 40, 60, 80, 100 and 
200 µg/ml) of SBE for 24 h followed by MTT for 4 
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h, and then 100 μl of isopropanol (in 0.04N 
hydrochloric acid) was added to dissolve the 
formazan crystals. The absorbance was read at 
570 nm using the Anthos 2010 
spectrophotometer (Salzburg, Austria). Cell 
viability was calculated as relative absorbance 
compared to control.  
 
Nitric oxide assay 
 
The amount of stable nitrite, the end product of 
NO generation, by activated microglia was 
determined by a colorimetric assay as previously 
described [14]. Briefly,BV-2 cells (2 x 105 
cells/ml) were seeded in 6-well plates in 500 μl 
complete culture medium and treated with the 
SBE extract at indicated concentrations (10, 20 
and 40 μg/ml) for 1 h prior stimulation with LPS 
(1 μg/ml) for 2 h. 50 μl of culture supernatant 
was mixed with an equal volume of Griess 
reagent and incubated at room temperature for 
10 min. The absorbance at 540 nm was read 
using a PowerWavex Microplate Scanning 
spectrophotometer (Bio-Tek Instrument, 
Winooski, VT, USA). Nitrite concentration was 
determined by extrapolation from a sodium nitrite 
standard curve. 
 
Nuclear protein extraction and Western blot 
analysis 
 
Cells were washed in cold PBS three times and 
lysed in a buffer containing 50 mM Tris-HCl, pH 
7.4, 1 % (v/v) Tergitol- type NP-40 (NP-40), 0.25 
% sodium deoxycholate, 150 mM NaCl, 1 mM 
EDTA, 25 mM NaF, 2 mM Sodium 
orthovanadate (Na3VO4) and protease inhibitor 
cocktail (Complete MiniTM, Roche, Mannheim, 
Germany) at 4 °C. The lysate was clarified by 
centrifugation at 10,000 g for 20 min at 4 °C to 
remove insoluble components. Cell lysates were 
normalized for protein content using 
bicinchoninic acid (BCA) reagent (Pierce, 
Rockford, IL, USA). Equal amounts of protein 
were loaded onto 10 % poly acryl amide gel 
electrophoresis (PAGE) and separated by 
standard sodium dodecyl sulphate (SDS)-PAGE 
procedure. Proteins were transferred to an NC 
membrane (S&S, Dassel, Germany) and blocked 
with 5% non-fat dry milk in TBS. To detect 
protein expression, the blots were probed with 
specific antibodies for iNOS (1:1000), COX-1 
(1:1000), COX-2 (1:1000), NF-κB, IκB-α 
(1:1000), anti-p-IκB-α and β-actin (1:2000) 
followed by a 1 h incubation with horseradish 
peroxidase–conjugated secondary antibodies 
(1:1000 – 2000)(Bio-Rad, Herculus, CA, USA) 
with β-actin as internal control. The 
immunoreactive proteins on the membrane were 
detected by chemiluminescence using the West-
Save substrate (Lab-Frontier, Seoul, Korea) on 
X-ray film. The antibodies against inducible nitric 
oxide synthase (iNOS), cyclooxygenase (COX) -
1, COX-2, nuclear factor kappa-B (NF-κB), I 
kappa B-alpha (IκB-α) and β-actin were 
purchased from Cell Signaling Technology Inc 
(Beverly, MA, USA).  
 
IL-6 assay  
 
BV-2 microglia cells (1 x 105 cells/well) were 
cultured on 96-well plates and treated with SBE 
at indicated concentrations with or without LPS 
(1μg/ml). At 4 h of post LPS treatment, the cells 
were collected and the supernatants were 
subjected to assay of IL-6 contents using a 
murine IL-6 ELISA kit from BD Biosciences (San 





BV-2 microglia cells (1 x 105 cells/well) were 
cultured on 96-well plates and treated with the 
SBE at indicated concentrations for 1 h and 
stimulated with LPS (1 μg/ml). At 4 h post-LPS 
treatment, the cells were collected and the 
supernatants were evaluated for TNF-α level 
using a murine TNF-α ELISA kit from BD 
Biosciences (San Jose, CA, USA) according to 




All data are represented as the mean ± SEM of 
at least three independent experiments. 
Statistical analyses were performed using SAS 
statistical software (SAS Institute, Cray, NC, 
USA) using one-way analysis of variance, 
followed by Dunnett's multiple range tests.      P 




Effect of SBE extract on DPPH radical 
scavenging activity  
 
As shown in Fig 1A, SBE exhibited significant 
DPPH radical scavenging activity in a 
concentration-dependent manner showing a 
maximum effect at 40 µg/ml of concentration   (p 
< 0.001). The ESR spectroscopy data is 
represented in Fig 1B. 
 
Effect of SBE on BV-2 microglial cell viability  
 
As shown in Fig. 2, SBE treatment for 24 hr at 
various concentrations ranging from 0.1 µg/ml to 
200 µg/ml did not exhibit any significant 
cytotoxicity on BV-2 microglial cells.  
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Fig 1: Effect of SBE on DPPH radical scavenging 
activity. The capacity to scavenge DPPH free radical 
by different concentrations of SBE (A) and ESR 
spectra (B) was measured. BV-2 cells were treated 
with or without SBE at the various concentrations (10, 
20, 40 and 80 µg/ml). The scavenging activity of each 
sample on DPPH radical was measured using a JES-
FA ESR spectrometer. A spin adduct was measured 
on an ESR spectrometer exactly 2 min later. Data are 
presented as the mean ± SEM (n = 3); **p < 0.01 and 
***p < 0.001, compared with control group by one-way 
analysis of variance, followed by Dunnett's multiple 
range tests. SBE = Salicornia bigelovii extract. 
 
 
Fig. 2: Effect of SBE on the viability of BV- 2 microglial 
cells. Viability in-SBE treated cells was determined 
using MTT assay. The results are depicted as 
percentage of control samples. Data are presented as 
the mean ± SEM (n = 3). SBE = Salicornia bigelovii 
extract. 
 
Effect of SBE on LPS-induced NO production 
in BV-2 microglial cells 
 
As shown in Fig 3, cells treated with LPS alone 
significantly increased the NO levels (p < 0.001). 
Pretreatment with SBE (10, 20, 40 and 80 μg/ml) 
significantly suppressed the LPS-stimulated 
increased NO release in BV-2 cells in a dose-
dependent manner compared to LPS only 
treated cells. The maximum effect was observed 
at a concentration of 100 μg/ml (p < 0.001).  
 
Effect of SBE on LPS-induced expression of 
iNOS and COX levels in BV-2 microglial cells 
 
SBE exhibited a broad spectrum of inhibitory 
effect on the expression of pro-inflammatory 
mediators and reduced the LPS-stimulated 
increase of protein expression such as iNOS and 
inducible COX-2 in a concentration-dependent 
manner. However, constitutive COX-1 protein 
expressional levels were uninterrupted (Fig 4).  
 
 
Fig 3: Effect of SBE on NO Production in LPS-
stimulated BV-2 microglial cells. BV-2 cells were 
treated with SBE at indicated concentrations (10, 20 
and 40 µg/ml) with or without LPS (1 µg/ml) for 4 h. 
The nitrite in the culture supernatant was evaluated 
using Griess reagent. Data are presented as the mean 
± S.E.M. (n = 3); #p < 0.001, when compared with 
control group. *p < 0.05, **p < 0.01 and ***p < 0.001, 
when compared with LPS alone treated group by one-
way analysis of variance, followed by Dunnett's 




Fig 4: Effect of SBE on iNOS, COX-1 and COX-2 
protein expressional levels in LPS-stimulated BV-2 
microglial cells. The expression levels of iNOS, COX-1 
and COX-2 production in the LPS-stimulated BV-2 
cells by various concentrations (10, 20 and 40 µg/ml) 
of the SBE was monitored by immunoblot analyses 
with the specific antibodies against iNOS, COX-1 and 
COX-2. The internal control used was β-actin. SBE = 
Salicornia bigelovii extract. 
 
Effect of SBE on TNF-α and IL-6 production in 
LPS-stimulated BV-2 microglial cells 
 
As shown in Fig 5, TNF-α level increased 
significantly after LPS treatment when compared 
to those in untreated cells (p<0.001). However, 
SBE significantly inhibited TNF-α production in a 
concentration dependent manner (p < 0.01 at 10 
μg/ml and p < 0.01 at 20 and p < 0.001 at 40 
μg/ml, respectively). LPS stimulation increased 
the IL-6 expression in BV- cells. However, 
pretreatment with SBE at various concentrations 
significantly and dose dependently decreased (p 
< 0.05 at 10 µg/ml, p < 0.01 at 20 µg/ml and p < 
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0.001 at 40 µg/ml) the LPS-induced IL-6 levels in 




Fig 5: Effect of SBE on pro-inflammatory cytokine 
TNF-α level in LPS-stimulated BV-2 cells. BV-2 cells 
were treated with SBE at indicated concentrations (10, 
20 and 40 µg/ml) with or without LPS (1 µg/ml) for 4 h. 
The TNF-α level in the culture supernatant was 
evaluated using a specific ELISA kit from BD Sciences 
according to the manufacturer’s instruction. Data are 
presented as the mean ± S.E.M. (n = 3). #p < 0.001, 
compared with control group. *p < 0.05, **p < 0.01, 
***p < 0.001, compared with LPS alone treated group 
by one-way analysis of variance, followed by 
Dunnett's multiple range tests. SBE = Salicornia 
bigelovii extract. 
 
Fig 6: Effect of SBE on pro-inflammatory cytokine IL-6 
expression in LPS-stimulated BV-2 cells. BV-2 cells 
were treated with SBE at indicated concentrations (10, 
20 and 40 µg/ml) with or without LPS (1 µg/ml) for 4 
hr. The IL-6 in the culture supernatant was evaluated 
using a murine IL-6 ELISA kit from BD Sciences 
according to the manufacturer’s instruction. Data are 
presented as the mean ± SEM (n = 3). #p<0.001, 
when compared with control group. *p < 0.05, **p < 
0.01, ***p < 0.001, compared with LPS alone treated 
group by one-way analysis of variance, followed by 
Dunnett's multiple range tests. SBE = Salicornia 
bigelovii extract. 
 
Effect of SBE on NF-κB in LPS-stimulated 
BV-2 microglial cells  
 
SBE inhibited the LPS-induced phosphorylation 
and degradation of IκB-α, and nuclear 
translocation of p65 NF-κB in a concentration 




Fig 7: Effect of SBE on NF-κB activity in LPS-
stimulated BV2 microglia. The expression levels of 
IκB-α, and nuclear translocation of p65 NF-κB in the 
LPS-stimulated BV-2 cells by indicated concentrations 
(10, 20 and 40 µg/ml) of the SBE was monitored by 
immunoblot analyses with the specific antibodies. The 
internal control used was β-actin. Data are presented 
as the mean ± SEM (n = 3) for three independent 




In the present study, proinflammatory stimulus 
by LPS to BV-2 cells resulted in excessive 
production of NO. Earlier studies revealed that 
prolonged activation of microglial cells leads to 
increased release of NO by iNOS in the brain. 
NO, an important regulatory mediator involved in 
cell survival and death exerts a number of pro-
inflammatory effects during several physiological 
and pathological processes leading to increased 
inflammatory reaction. It was well known that 
COX-1 is constitutively expressed in many cell 
types and COX-2 is normally not present in most 
cells, but its expression is induced in response to 
inflammatory cytokines linked to pathological 
events [15]. COX-2 is upregulated in response to 
various inflammatory stimuli including LPS in BV-
2 microglia. Therefore, agents that inhibit the 
release of NO and attenuate iNOS and COX-2 
expression could be beneficial for preventing and 
delaying the progression of neuroinflammatory 
disease. [16]. Data from our study clearly 
showed that SBE attenuated LPS-induced iNOS 
and COX-2 expression and downstream NO 
production. However, SBE has no influence on 
the constitutive COX-1 expression.  
 
Pro-inflammatory cytokines such as TNF-α, IL-
1β, and IL-6 play central roles in microglia-
mediated inflammation [17]. In particular, 
increased levels of brain TNF-α and IL-6 has 
been associated with severe cognitive 
impairments, neuronal damage and 
neuroinflammation [17]. Therefore, the effects of 
SBE on proinflammatory cytokine TNF- α and IL-
6 production in LPS-stimulated BV-2 microglial 
cells were evaluated. LPS-stimulation increased 
the levels of TNF- α and IL-6 in BV-2 cells. 
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However, pretreatment with SBE suppressed the 
increased TNF- α and IL-6 production indicating 
that SBE may convincingly be an effective anti-
neuroinflammatory agent.  
 
NF-κB, a mammalian transcription factor, 
activated by LPS, is known to control the 
expression of cell survival genes as well as pro-
inflammatory enzymes and cytokines [18]. Our 
result showed that SBE inhibited the LPS-
induced phosphorylation/degradation of IκB-α 
and translocation of NF-κB/p65 sub unit in a 
concentration-dependent manner. Considering 
the above data, we can conclude that NF-κB is a 
major target of SBE. However, the exact 
molecular target of SBE on NF-κB activation 
remains to be elucidated. 
 
The mechanism of neuro-inflammation is partly 
attributed, to release of toxic free radicals and 
ROS from activated microglia which may 
participate in the neurodegenerative process. 
DPPH radical assay is one of the widely used 
methods for screening the free radical 
scavenging activities of several agents in a 
relatively short period of time. In the present 
study, SBE significantly scavenged the DPPH 
free radicals. Reports from earlier studies 
indicated that S. bigelovii posses active 
constituents such as triterpenoids, flavones, 
glycosides, saponins, vitamins and minerals 
[3,19]. Salicornia species were also reported to 
posses’ strong anti-oxidant properties [20,21]. In 
light of such reports, the strong anti-oxidant 
activity exhibited by SBE supports the notion that 
SBE might play a promising role in exhibiting 
anti-neuroinflammatory properties in LPS-




This study revealed for the first time that SBE 
inhibits neuro-inflammatory responses via NF-κB 
signaling in LPS-stimulated BV-2 microglial cells. 
Further, the antioxidant potential of SBE might 
partly be involved for the observed effects.  
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